![]()
|
|
||||||||
J. Biol. Chem., Vol. 263, Issue 16, 7500-7505, 06, 1988
S Berliner, K Niiya, JR Roberts, RA Houghten and ZM Ruggeri
We have generated antibodies against a synthetic peptide corresponding to
the sequence of human von Willebrand factor (vWF) between residues
Glu1737-Ser1750 which includes the Arg-Gly-Asp sequence common to several
adhesive molecules. Two anti-peptide antibodies, one polyclonal, and one
monoclonal reacted with native vWF and inhibited its binding to platelet
glycoprotein (GP) IIb-IIIa, but showed negligible cross-reactivity with
fibrinogen, fibronectin, and vitronectin, three other molecules that
contain the sequence Arg-Gly- Asp and bind to platelets. The structural
bases for the specificity of the two antibodies were evaluated by testing
the ability of peptides homologous to the parent sequence, but with single
amino acid substitutions, to neutralize the binding of the two antibodies
to vWF. The substitution of Pro1743, the residue immediately adjacent to
the Arg-Gly-Asp sequence on the amino-terminal side, with Phe resulted in a
peptide that failed to interact with either antibody. Thus, Pro1743 is
important for maintaining a peptide conformation recognized by two
antibodies specific for the GP IIb-IIIa-binding domain of vWF. Other
residues important for optimal peptide reactivity with the polyclonal
antibody were Ser1742, Arg1744, and Gly1745, whereas Gly1741, Gly1745, and
Asp1746, but not Arg1744, were important for reactivity with the monoclonal
antibody. The epitopes of both antibodies, therefore, included at least 2
of the residues in the sequence Arg-Gly-Asp considered the common
cell-binding site of adhesive molecules that interact with GP IIb-IIIa.
Nevertheless, both antibodies reacted only with vWF. These studies
demonstrate that peptide-specific antibodies, unlike the promiscuous GP
IIb-IIIa receptor, can recognize distinctive structural characteristics of
the cell-binding domain of adhesive molecules imposed by residues adjacent
to the sequence Arg-Gly-Asp.
Generation and characterization of peptide-specific antibodies that inhibit von Willebrand factor binding to glycoprotein IIb-IIIa without interacting with other adhesive molecules. Selectivity is conferred by Pro1743 and other amino acid residues adjacent to the sequence Arg1744- Gly1745-Asp1746
Department of Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, California 92037.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Vasudevan, J. R. Roberts, R. A. McClintock, J. A. Dent, R. Celikel, J. Ware, K. I. Varughese, and Z. M. Ruggeri Modeling and Functional Analysis of the Interaction between von Willebrand Factor A1 Domain and Glycoprotein Ibalpha J. Biol. Chem., April 21, 2000; 275(17): 12763 - 12768. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, L. B. Coons, D. B. Taylor, S. E. Stevens Jr., and T. K. Gartner Variabilin, a Novel RGD-containing Antagonist of Glycoprotein IIb-IIIa and Platelet Aggregation Inhibitor from the Hard Tick Dermacentor variabilis J. Biol. Chem., July 26, 1996; 271(30): 17785 - 17790. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mohri, J. Tanabe, K. Katoh, and T. Okubo Identification of a Novel Binding Site to the Integrin alpha IIbbeta 3 Located in the C-terminal Heparin-binding Domain of Human Plasma Fibronectin J. Biol. Chem., June 28, 1996; 271(26): 15724 - 15728. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goto, D. R. Salomon, Y. Ikeda, and Z. M. Ruggeri Characterization of the Unique Mechanism Mediating the Shear-dependent Binding of Soluble von Willebrand Factor to Platelets J. Biol. Chem., October 6, 1995; 270(40): 23352 - 23361. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |